Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Stage

Acquired Unit | Acquired

Valuation

$0000 

About Novartis - Generics Unit

Novartis (NYSE: NVS) is a global healthcare company that provides solutions to address the evolving needs of patients worldwide. Focusing solely on healthcare, Novartis offers a diversified portfolio to meet these needs including medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools, and consumer health products.

Novartis - Generics Unit Headquarters Location

Forum 1 Novartis Campus

Basel, 4056,

Switzerland

+41 61 324 11 11

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

  • Where is Novartis - Generics Unit's headquarters?

    Novartis - Generics Unit's headquarters is located at Forum 1, Basel.

  • What is Novartis - Generics Unit's latest funding round?

    Novartis - Generics Unit's latest funding round is Acquired Unit.

  • Who are the investors of Novartis - Generics Unit?

    Investors of Novartis - Generics Unit include Aurobindo Pharma.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.